NG
UTHR icon

Norden Group’s United Therapeutics UTHR Stock Holding History

Norden Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Sell
608
-2
-0.3% -$1.13K 0.03% 496
2026
Q1 		$362K Buy
610
+44
+8% +$21.9K 0.03% 412
2025
Q4 		$276K Buy
+566
New +$264K 0.03% 491

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Norden Group's UTHR Position: Q2 2026 in Review

Norden Group reduced its United Therapeutics (UTHR) stake by 0.33% in Q2 2026, selling an estimated $1.13K and leaving 608 shares worth $329K. The position accounts for 0.03% of the portfolio, ranked #496.

Norden Group first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $362K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Norden Group held 608 shares of United Therapeutics worth $329K as of Q2 2026.
  • Norden Group sold 2 United Therapeutics shares in Q2 2026, an estimated $1.13K.
  • United Therapeutics made up 0.03% of Norden Group's portfolio in Q2 2026, its #496 holding.
  • Norden Group first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Norden Group's United Therapeutics position peaked at $362K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.